Diazoxide attenuates DOX-induced cardiotoxicity in cultured rat myocytes
dc.authorid | Sevgiler, Yusuf/0000-0002-4373-2389 | en_US |
dc.authorscopusid | 6602873428 | en_US |
dc.authorscopusid | 36543258600 | en_US |
dc.authorscopusid | 58925924400 | en_US |
dc.authorscopusid | 55515395600 | en_US |
dc.authorscopusid | 56152285300 | en_US |
dc.authorwosid | Sevgiler, Yusuf/S-7015-2016 | en_US |
dc.contributor.author | Guven, Celal | |
dc.contributor.author | Taskin, Eylem | |
dc.contributor.author | Aydin, Ozgul | |
dc.contributor.author | Kaya, Salih Tunc | |
dc.contributor.author | Sevgiler, Yusuf | |
dc.date.accessioned | 2024-08-23T16:04:28Z | |
dc.date.available | 2024-08-23T16:04:28Z | |
dc.date.issued | 2024 | en_US |
dc.department | Düzce Üniversitesi | en_US |
dc.description.abstract | Doxorubicin (DOX)-induced cardiotoxicity is a well known clinical problem, and many investigations have been made of its possible amelioration. We have investigated whether diazoxide (DIA), an agonist at mitochondrial ATP-sensitive potassium channels (mitoKATP), could reverse DOX-induced apoptotic myocardial cell loss, in cultured rat cardiomyocytes. The role of certain proteins in this pathway was also studied. The rat cardiomyocyte cell line (H9c2) was treated with DOX, and also co-treated with DOX and DIA, for 24 h. Distribution of actin filaments, mitochondrial membrane potential, superoxide dismutase (SOD) activity, total oxidant and antioxidant status (TOS and TAS, respectively), and some protein expressions, were assessed. DOX significantly decreased SOD activity, increased ERK1/2 protein levels, and depolarised the mitochondrial membrane, while DIA co-treatment inhibited such changes. DIA co-treatment ameliorated DOX-induced cytoskeletal changes via F-actin distribution and mitoKATP structure. Co-treatment also decreased ERK1/2 and cytochrome c protein levels. Cardiomyocyte loss due to oxidative stress-mediated apoptosis is a key event in DOX-induced cytotoxicity. DIA had protective effects on DOX-induced cardiotoxicity, via mitoKATP integrity, especially with elevated SUR2A levels; but also by a cascade including SOD/AMPK/ERK1/2. Therefore, DIA may be considered a candidate agent for protecting cardiomyocytes against DOX chemotherapy. | en_US |
dc.description.sponsorship | Adimath;yaman University Scientific Research Commission [FEFYL/2018-0001] | en_US |
dc.description.sponsorship | We gratefully acknowledge Ad & imath;yaman University Scientific Research Commission for their support by provision of Grant no. FEFYL/2018-0001. We also thank Dr Muhsin Ayd & imath;n for editing the manuscript. | en_US |
dc.identifier.doi | 10.1080/10520295.2024.2324368 | |
dc.identifier.endpage | 124 | en_US |
dc.identifier.issn | 1052-0295 | |
dc.identifier.issn | 1473-7760 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 38439686 | en_US |
dc.identifier.scopus | 2-s2.0-85187187292 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 113 | en_US |
dc.identifier.uri | https://doi.org/10.1080/10520295.2024.2324368 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/14210 | |
dc.identifier.volume | 99 | en_US |
dc.identifier.wos | WOS:001179066800001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Biotechnic & Histochemistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | ATP-sensitive potassium channels | en_US |
dc.subject | diazoxide | en_US |
dc.subject | doxorubicin | en_US |
dc.subject | oxidative stress | en_US |
dc.subject | Sensitive Potassium Channels | en_US |
dc.subject | Activated Protein-Kinase | en_US |
dc.subject | K-Atp Channels | en_US |
dc.subject | Actin Cytoskeleton | en_US |
dc.subject | Angiotensin-Ii | en_US |
dc.subject | Cardioprotection | en_US |
dc.subject | Mitochondria | en_US |
dc.subject | Doxorubicin | en_US |
dc.subject | Phosphorylation | en_US |
dc.subject | Dysfunction | en_US |
dc.title | Diazoxide attenuates DOX-induced cardiotoxicity in cultured rat myocytes | en_US |
dc.type | Article | en_US |